Inicio600535 • SHA
add
Tasly Pharmaceutical Group Co Ltd
Cierre anterior
13,99 ¥
Intervalo diario
13,93 ¥ - 14,09 ¥
Intervalo anual
12,24 ¥ - 17,77 ¥
Cap. bursátil
20,33 mil M CNY
Volumen medio
9,90 M
Relación precio-beneficio
23,87
Rentabilidad por dividendo
2,94 %
Bolsa de valores principal
SHA
Noticias sobre los mercados
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
(CNY) | sept 2024info | Cambio interanual |
---|---|---|
Ingresos | 2090,82 M | -4,06 % |
Gastos operativos | 1027,96 M | -2,03 % |
Ingresos netos | 179,89 M | -44,67 % |
Margen de beneficio neto | 8,60 | -42,36 % |
Beneficios por acción | — | — |
EBITDA | 441,72 M | -18,76 % |
Tipo impositivo efectivo | 14,16 % | — |
Balance general
Activos totales
Responsabilidades totales
(CNY) | sept 2024info | Cambio interanual |
---|---|---|
Efectivo y a corto plazo | 4967,78 M | 13,35 % |
Activos totales | 16,83 mil M | -4,76 % |
Responsabilidades totales | 3817,22 M | -22,94 % |
Patrimonio total | 13,02 mil M | — |
Acciones en circulación | 1493,95 M | — |
Precio-valor contable | 1,64 | — |
Rentabilidad económica | 4,92 % | — |
Retorno sobre capital | 5,52 % | — |
Flujo de caja
Variación neta del flujo de caja
(CNY) | sept 2024info | Cambio interanual |
---|---|---|
Ingresos netos | 179,89 M | -44,67 % |
Efectivo de operaciones | 303,22 M | 22,05 % |
Efectivo de inversión | -260,81 M | -362,16 % |
Efectivo de financiación | -992,53 M | -2.032,67 % |
Variación neta del flujo de caja | -951,66 M | -338,75 % |
Flujo de caja libre | -824,52 M | -1.070,21 % |
Información sobre la empresa
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
Fundación
1994
Sitio web
Empleados
9.223